Orthogonal and multiplexable genetic perturbations with an engineered prime editor and a diverse RNA array
Open Access
- 30 December 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-12
Abstract
Programmable and modular systems capable of orthogonal genomic and transcriptomic perturbations are crucial for biological research and treating human genetic diseases. Here, we present the minimal versatile genetic perturbation technology (mvGPT), a flexible toolkit designed for simultaneous and orthogonal gene editing, activation, and repression in human cells. The mvGPT combines an engineered compact prime editor (PE), a fusion activator MS2–p65–HSF1 (MPH), and a drive-and-process multiplex array that produces RNAs tailored to different types of genetic perturbation. mvGPT can precisely edit human genome via PE coupled with a prime editing guide RNA and a nicking guide RNA, activate endogenous gene expression using PE with a truncated single guide RNA containing MPH-recruiting MS2 aptamers, and silence endogenous gene expression via RNA interference with a short-hairpin RNA. We showcase the versatility of mvGPT by simultaneously correcting a c.3207C>A mutation in the ATP7B gene linked to Wilson’s disease, upregulating the PDX1 gene expression to potentially treat Type I diabetes, and suppressing the TTR gene to manage transthyretin amyloidosis. In addition to plasmid delivery, we successfully utilize various methods to deliver the mvGPT payload, demonstrating its potential for future in vivo applications.Keywords
Funding Information
- National Science Foundation (CBET-2143626)
This publication has 59 references indexed in Scilit:
- Chromatin context-dependent regulation and epigenetic manipulation of prime editingCell, 2024
- Recent advances in prime editing technologies and their promises for therapeutic applicationsCurrent Opinion in Biotechnology, 2024
- Phage-assisted evolution and protein engineering yield compact, efficient prime editorsCell, 2023
- Revolutionizing genetic disease treatment: Recent technological advances in base editingCurrent Opinion in Biomedical Engineering, 2023
- Enhanced prime editing systems by manipulating cellular determinants of editing outcomesCell, 2021
- In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic ModulationCell, 2017
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene ExpressionCell, 2013
- A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content ScreenCell, 2006
- A short amino acid sequence able to specify nuclear locationCell, 1984
- A polypeptide domain that specifies migration of nucleoplasmin into the nucleusCell, 1982